H&H Health Care & Cosmetics Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 31-10-2024
- Paid Up Capital ₹ 5.51 Cr
as on 31-10-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 60.11 Cr
as on 31-10-2024
- Satisfied Charges ₹ 24.40 Cr
as on 31-10-2024
- Revenue %
(FY 2023)
- Net Worth 0.09%
(FY 2023)
- Total Assets 325.06%
(FY 2023)
About H&H Health Care & Cosmetics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.51 Cr.
The company currently has active open charges totaling ₹60.11 Cr. The company has closed loans amounting to ₹24.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vaibhav Rai and Harshul Rai serve as directors at the Company.
- CIN/LLPIN
U24304MP2020PTC051641
- Company No.
051641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at H&H Health Care & Cosmetics?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vaibhav Rai | Director | 29-Jun-2020 | Current |
Harshul Rai | Director | 29-Jun-2020 | Current |
Financial Performance of H&H Health Care & Cosmetics.
H&H Health Care & Cosmetics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of H&H Health Care & Cosmetics?
In 2023, H&H Health Care & Cosmetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Micromitti Real Estate Ventures Private LimitedActive 1 year 4 months
Vaibhav Rai is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 03 Jan 2024 | ₹9.73 M | Open |
Others Creation Date: 27 Jul 2023 | ₹2.70 Cr | Open |
Others Creation Date: 14 Dec 2022 | ₹2.10 M | Open |
How Many Employees Work at H&H Health Care & Cosmetics?
H&H Health Care & Cosmetics has a workforce of 117 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of H&H Health Care & Cosmetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped H&H Health Care & Cosmetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.